Publication

This report examines the process of assessing applications for genetically modified (GM) crops or plants for import or commercial planting in Norway. According to the author, a growing consensus about applications seems to represent a puzzle, going counter to post-moratorium trends in the EU. The report identifies a central difference with the EU processes in the emanation from specific clauses in the Norwegian Gene Technology Act on sustainable development and societal utility, which provides a wider leverage for Norwegian authorities to turn down the applications.